Open Access
Issue
J Extra Corpor Technol
Volume 50, Number 2, June 2018
Page(s) 117 - 119
DOI https://doi.org/10.1051/ject/201850117
Published online 15 June 2018
  1. Sutton SW, Hunley EK, Duncan MA, et al. Sickle cell disease and aortic valve replacement, use of cardiopulmonary bypass, partial exchange transfusion, platelet sequestration, and continuous hemofiltration. Tex Heart Inst J. 1999;26:283–8. [PubMed] [Google Scholar]
  2. Bocchieri KA, Scheinerman SJ, Graver LM Exchange transfusion before cardiopulmonary bypass in sickle cell disease. Ann Thorac Surg. 2010;90:323–4. [CrossRef] [PubMed] [Google Scholar]
  3. Chabot D, Sutton R Mitral valve replacement in a patient with sickle cell disease using perioperative exchange transfusion. J Extra Corpro Technol. 2008;40:275–7. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  4. Aliyu ZY, Tumblin AR, Kato GJ Current therapy of sickle cell disease. Haematologica. 2006;91:7–10. [PubMed] [Google Scholar]
  5. Maddali MM, Rajakumar MC, Fahr J, et al. Cardiopulmonary bypass without preoperative exchange transfusion in sicklers. Asian Cardiovasc Thorac Ann. 2006;14:51–6. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.